Lishen Zhang

3.3k total citations · 2 hit papers
30 papers, 2.0k citations indexed

About

Lishen Zhang is a scholar working on Molecular Biology, Biomedical Engineering and Surfaces, Coatings and Films. According to data from OpenAlex, Lishen Zhang has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Biomedical Engineering and 5 papers in Surfaces, Coatings and Films. Recurrent topics in Lishen Zhang's work include Surface Modification and Superhydrophobicity (5 papers), Biosensors and Analytical Detection (5 papers) and Advanced Sensor and Energy Harvesting Materials (5 papers). Lishen Zhang is often cited by papers focused on Surface Modification and Superhydrophobicity (5 papers), Biosensors and Analytical Detection (5 papers) and Advanced Sensor and Energy Harvesting Materials (5 papers). Lishen Zhang collaborates with scholars based in China, Canada and United States. Lishen Zhang's co-authors include Wei Xiong, Zhaoyang Zeng, Can Guo, Hua‐Zhong Yu, Guiyuan Li, Yu Lian, Jianda Zhou, Xiayu Li, Ke Cao and Zhaojian Gong and has published in prestigious journals such as Nature Communications, Bioinformatics and Scientific Reports.

In The Last Decade

Lishen Zhang

28 papers receiving 2.0k citations

Hit Papers

Role of tumor microenvironment in tumorigenesis 2017 2026 2020 2023 2017 2021 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lishen Zhang China 15 663 489 487 391 336 30 2.0k
Xiang Yan China 25 740 1.1× 481 1.0× 472 1.0× 483 1.2× 220 0.7× 142 3.0k
Ian Lian United States 16 1.8k 2.6× 342 0.7× 226 0.5× 161 0.4× 202 0.6× 30 3.1k
Kyoko Shimizu Japan 25 722 1.1× 943 1.9× 140 0.3× 373 1.0× 188 0.6× 116 2.4k
Wenge Liu United States 23 1.1k 1.6× 274 0.6× 1000 2.1× 172 0.4× 144 0.4× 59 3.1k
Anke Schmidt Germany 38 832 1.3× 165 0.3× 579 1.2× 83 0.2× 109 0.3× 71 3.6k
Dong Gil You South Korea 32 1.2k 1.8× 160 0.3× 2.0k 4.2× 281 0.7× 304 0.9× 75 3.7k
Yi Du China 28 1.8k 2.6× 1.4k 2.8× 214 0.4× 660 1.7× 480 1.4× 67 3.7k
Peng Guo China 29 1.2k 1.8× 394 0.8× 947 1.9× 252 0.6× 219 0.7× 109 2.8k
Xin Ji China 29 669 1.0× 228 0.5× 817 1.7× 190 0.5× 141 0.4× 145 3.0k
Axel Sckell Germany 20 725 1.1× 247 0.5× 328 0.7× 352 0.9× 130 0.4× 36 1.9k

Countries citing papers authored by Lishen Zhang

Since Specialization
Citations

This map shows the geographic impact of Lishen Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lishen Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lishen Zhang more than expected).

Fields of papers citing papers by Lishen Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lishen Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lishen Zhang. The network helps show where Lishen Zhang may publish in the future.

Co-authorship network of co-authors of Lishen Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lishen Zhang. A scholar is included among the top collaborators of Lishen Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lishen Zhang. Lishen Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Ruiyang, Feifei Hou, Lishen Zhang, et al.. (2025). Metformin-induced E6/E7 inhibition prevents HPV-positive cancer progression through p53 reactivation. Anti-Cancer Drugs. 36(6). 468–477.
3.
Zhang, Yixin, Lishen Zhang, Dan Yang, et al.. (2025). Microbial-triggered integrated stress response in sulcular and junctional keratinocytes exacerbates immunopathology in periodontitis. International Immunopharmacology. 169. 115965–115965.
4.
Li, Hong‐Dong, et al.. (2024). Identifying new cancer genes based on the integration of annotated gene sets via hypergraph neural networks. Bioinformatics. 40(Supplement_1). i511–i520. 6 indexed citations
5.
Zhao, Haochen, et al.. (2024). RGCNPPIS: A Residual Graph Convolutional Network for Protein-Protein Interaction Site Prediction. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 21(6). 1676–1684. 9 indexed citations
6.
Liu, Jiawei, Yan Yang, Yanfeng Hou, et al.. (2024). Stretchable and High‐Performance Fibrous Sensors Based on Ionic Capacitive Sensing for Wearable Healthcare Monitoring. Advanced Science. 12(1). e2412859–e2412859. 19 indexed citations
7.
Zhang, Lishen, et al.. (2023). A universally adaptable micropatterning method through laser-induced wettability inversion. Sensors and Actuators B Chemical. 390. 133983–133983. 4 indexed citations
8.
Wang, Liyan, Shoukun Ji, Jinhui Li, et al.. (2023). Dose-Response of Fruit Oligosaccharides on Rumen Fermentation Parameters, CH4 Emission and Skatole Content In Vitro. Fermentation. 9(5). 428–428. 1 indexed citations
9.
Zhang, Lishen, et al.. (2023). Micro “Hyper‐Channels” on Laser‐Refined Cellulose Structures. Small Methods. 8(3). e2301164–e2301164. 1 indexed citations
10.
12.
Zhang, Lishen, et al.. (2022). Meso-substituented pyronine: colorful emission and versatile platform for the rational design of fluorescent probes. Coordination Chemistry Reviews. 461. 214507–214507. 9 indexed citations
13.
Yan, Minmin, Lishen Zhang, Pengjuan Sun, et al.. (2022). Explorations into the meso-substituted BODIPY-based fluorescent probes for biomedical sensing and imaging. TrAC Trends in Analytical Chemistry. 157. 116771–116771. 24 indexed citations
14.
Zhang, Lishen, et al.. (2021). Functional and versatile superhydrophobic coatings via stoichiometric silanization. Nature Communications. 12(1). 982–982. 244 indexed citations breakdown →
15.
Huang, Bin, Yun Cai, Ning Li, et al.. (2021). Sex-based clinical and immunological differences in COVID-19. BMC Infectious Diseases. 21(1). 647–647. 26 indexed citations
16.
Zhang, Lishen, et al.. (2020). Superhydrophobic Glass Microfiber Filter as Background-Free Substrate for Quantitative Fluorometric Assays. ACS Applied Materials & Interfaces. 12(6). 7665–7672. 21 indexed citations
17.
Zhang, Lishen, et al.. (2019). Binary Silanization and Silver Nanoparticle Encapsulation to Create Superhydrophobic Cotton Fabrics with Antimicrobial Capability. Scientific Reports. 9(1). 9172–9172. 25 indexed citations
18.
Mo, Yongzhen, Yumin Wang, Lishen Zhang, et al.. (2019). The role of Wnt signaling pathway in tumor metabolic reprogramming. Journal of Cancer. 10(16). 3789–3797. 88 indexed citations
19.
Wang, Maonan, Lishen Zhang, Wei Fang, et al.. (2017). Role of tumor microenvironment in tumorigenesis. Journal of Cancer. 8(5). 761–773. 1023 indexed citations breakdown →
20.
Liu, Jing, Yuanqiang Sun, Jingyu Zhang, et al.. (2013). A Ratiometric Fluorescent Probe for Biological Signaling Molecule H2S: Fast Response and High Selectivity. Chemistry - A European Journal. 19(15). 4717–4722. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026